Alberta Investment Management Corp Vanda Pharmaceuticals Inc. Transaction History

Alberta Investment Management Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$6.87 - $10.96 $15,354 - $24,495	-2,235 Reduced 4.21%	50,875 $375,000
Q3 2022 Nov 14, 2022	BUY	$9.44 - $11.76 $501,358 - $624,573	53,110 New	53,110 $525,000
Q2 2022 Aug 15, 2022	SELL	$9.31 - $11.84 $1.01 Million - $1.28 Million	-107,985 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$13.42 - $20.28 $626,512 - $946,771	46,685 Added 76.16%	107,985 $1.62 Million
Q4 2020 Feb 16, 2021	BUY	$9.77 - $13.81 $286,261 - $404,633	29,300 Added 91.56%	61,300 $805,000
Q3 2020 Oct 26, 2020	BUY	$9.32 - $12.02 $298,240 - $384,640	32,000 New	32,000 $309,000
Q1 2020 May 08, 2020	SELL	$7.5 - $16.8 $302,250 - $677,040	-40,300 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$12.38 - $17.47 $378,828 - $534,582	-30,600 Reduced 43.16%	40,300 $661,000
Q3 2019 Oct 23, 2019	BUY	$12.27 - $15.79 $869,943 - $1.12 Million	70,900 New	70,900 $942,000

161

45.2M

165K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $278M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Alberta Investment Management Corp, based on Form 13F filings with the SEC.

Stay updated on Alberta Investment Management Corp with notifications on news.